Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk
在复发风险增加的绝经前早期激素受体阳性、HER2阴性乳腺癌患者中，芳香化酶抑制剂、他莫昔芬和卵巢功能抑制的实际应用情况
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104458
Müller, Volkmar; Hörner, Manuel; Thill, Marc; Banys-Paluchowski, Maggie; Schmatloch, Sabine; Fasching, Peter A; Harbeck, Nadia; Langanke, Dagmar; Uhrig, Sabrina; Häberle, Lothar; Fischer, Dorothea; Hein, Alexander; Fehm, Tanja N; Goossens, Chloë; Terhaag, Jürgen; Heilenkötter, Uwe; Dall, Peter; Rudlowski, Christian; Wuerstlein, Rachel; Aydogdu, Mustafa; Keyver-Paik, Mignon-Denise; Hammerle, Carolin; Deuerling, Natalija; Stickeler, Elmar; Aktas, Bahriye; Belleville, Erik; Thoma, Martin; Ditsch, Nina; Baila, Yasmin; Roos, Christian; Mann, Christian; Iuliano, Caterina; Brucker, Sara Y; Schneeweiss, Andreas; Hartkopf, Andreas D
